Canaccord Genuity Group Has Lowered Expectations for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its target price cut by Canaccord Genuity Group from $36.00 to $34.00 in a research report report published on Monday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on the stock. Scotiabank raised their […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its target price cut by Canaccord Genuity Group from $36.00 to $34.00 in a research report report published on Monday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on the stock. Scotiabank raised their […]
